CXCR4 and cancer: To test whether CXCR4:ADC/antibody internalization rates differ between normal and cancer cells, we measured the kinetics of anti-CXCR4 h17-NV.TS (antibody backbone of ADC 713) delivery to lysosome in human cancer cells and normal PBMCs in vitro.